These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385 [TBL] [Abstract][Full Text] [Related]
10. Management of postoperative recurrence of Crohn's disease. van Lent AU; D'Haens GR Dig Dis; 2013; 31(2):222-8. PubMed ID: 24030230 [TBL] [Abstract][Full Text] [Related]
11. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy. Amiot A; Gornet JM; Baudry C; Munoz-Bongrand N; Auger M; Simon M; Allez M; Cattan P; Sarfati E; Lémann M Dig Liver Dis; 2011 Sep; 43(9):698-702. PubMed ID: 21474398 [TBL] [Abstract][Full Text] [Related]
12. Role of immunosuppressives in special situations: perianal disease and postoperative period. Ghosh S; Iacucci M Dig Dis; 2014; 32 Suppl 1():92-5. PubMed ID: 25531359 [TBL] [Abstract][Full Text] [Related]
13. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis. Uchino M; Ikeuchi H; Hata K; Minagawa T; Horio Y; Kuwahara R; Nakamura S; Watanabe K; Saruta M; Fujii T; Kobayashi T; Sugimoto K; Hirai F; Esaki M; Hiraoka S; Matsuoka K; Shinzaki S; Matsuura M; Inoue N; Nakase H; Watanabe M J Gastroenterol Hepatol; 2021 Apr; 36(4):864-872. PubMed ID: 33002235 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological Prevention and Management of Postoperative Relapse in Pediatric Crohn's Disease. Yerushalmy-Feler A; Assa A Paediatr Drugs; 2019 Dec; 21(6):451-460. PubMed ID: 31628665 [TBL] [Abstract][Full Text] [Related]
15. Strategies for the prevention of postoperative recurrence of Crohn's disease. Yamamoto T; Watanabe T Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911 [TBL] [Abstract][Full Text] [Related]
16. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort. van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041 [TBL] [Abstract][Full Text] [Related]
17. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204 [TBL] [Abstract][Full Text] [Related]
18. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection. Li Y; Stocchi L; Rui Y; Remzi FH; Shen B Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090 [TBL] [Abstract][Full Text] [Related]
19. Factors affecting recurrence after surgery for Crohn's disease. Yamamoto T World J Gastroenterol; 2005 Jul; 11(26):3971-9. PubMed ID: 15996018 [TBL] [Abstract][Full Text] [Related]
20. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis. Cañete F; Mañosa M; Pérez-Martínez I; Barreiro-de Acosta M; González-Sueyro RC; Nos P; Iglesias-Flores E; Gutiérrez A; Bujanda L; Gordillo J; Ríos León R; Casanova MJ; Villoria A; Rodríguez-Lago I; López Serrano P; García-Herola A; Ramírez-de la Piscina P; Navarro-Llavat M; Taxonera C; Barrio J; Ramos L; Navarro P; Benítez-Leiva O; Calafat M; Domènech E; Clin Transl Gastroenterol; 2020 Aug; 11(8):e00218. PubMed ID: 32955190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]